Literature DB >> 30267801

Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis.

Martin Hoenigl1, Thomas Orasch2, Klaus Faserl3, Juergen Prattes4, Juergen Loeffler5, Jan Springer5, Fabio Gsaller2, Frederike Reischies6, Wiebke Duettmann6, Reinhard B Raggam7, Herbert Lindner8, Hubertus Haas9.   

Abstract

OBJECTIVES: Early diagnosis of invasive aspergillosis (IA) remains challenging, with available diagnostics being limited by inadequate sensitivities and specificities. Triacetylfusarinine C, a fungal siderophore that has been shown to accumulate in urine in animal models, is a potential new biomarker for diagnosis of IA.
METHODS: We developed a method allowing absolute and matrix-independent mass spectrometric quantification of TAFC. Urine TAFC, normalized to creatinine, was determined in 44 samples from 24 patients with underlying hematologic malignancies and probable, possible or no IA according to current EORTC/MSG criteria and compared to other established biomarkers measured in urine and same-day blood samples.
RESULTS: TAFC/creatinine sensitivity, specificity, positive and negative likelihood ratio for probable versus no IA (cut-off ≥ 3) were 0.86, 0.88, 6.86, 0.16 per patient.
CONCLUSION: For the first time, we provide proof for the occurrence of TAFC in human urine. TAFC/creatinine index determination in urine showed promising results for diagnosis of IA offering the advantages of non-invasive sampling. Sensitivity and specificity were similar as reported for GM determination in serum and bronchoalveolar lavage, the gold standard mycological criterion for IA diagnosis.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Aspergillosis; Biomarker; Diagnosis; Siderophore; Urine

Mesh:

Substances:

Year:  2018        PMID: 30267801      PMCID: PMC6361682          DOI: 10.1016/j.jinf.2018.09.006

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  43 in total

1.  Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies.

Authors:  Marcio Nucci; Simone Aranha Nouér; Monica Grazziutti; Naveen Sanath Kumar; Bart Barlogie; Elias Anaissie
Journal:  Clin Infect Dis       Date:  2010-10-29       Impact factor: 9.079

2.  The Aspergillus fumigatus siderophore biosynthetic gene sidA, encoding L-ornithine N5-oxygenase, is required for virulence.

Authors:  Anna H T Hissen; Adrian N C Wan; Mark L Warwas; Linda J Pinto; Margo M Moore
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.

Authors:  Oliver A Cornely; Johan Maertens; Drew J Winston; John Perfect; Andrew J Ullmann; Thomas J Walsh; David Helfgott; Jerzy Holowiecki; Dick Stockelberg; Yeow-Tee Goh; Mario Petrini; Cathy Hardalo; Ramachandran Suresh; David Angulo-Gonzalez
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

4.  Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-08-15       Impact factor: 9.079

5.  Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus.

Authors:  Sabiha Yasmin; Laura Alcazar-Fuoli; Mario Gründlinger; Thomas Puempel; Timothy Cairns; Michael Blatzer; Jordi F Lopez; Joan O Grimalt; Elaine Bignell; Hubertus Haas
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

6.  Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.

Authors:  Juergen Prattes; Michaela Lackner; Susanne Eigl; Frederike Reischies; Reinhard B Raggam; Christoph Koidl; Holger Flick; Robert Wurm; Michael Palfner; Albert Wölfler; Peter Neumeister; Christopher R Thornton; Robert Krause; Cornelia Lass-Flörl; Martin Hoenigl
Journal:  Mycoses       Date:  2015-06-23       Impact factor: 4.377

7.  Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.

Authors:  Zdenek Racil; Iva Kocmanova; Martina Toskova; Lucie Buresova; Barbora Weinbergerova; Martina Lengerova; Monika Rolencova; Jana Winterova; Kristyna Hrncirova; Pavlina Volfova; Jana Skrickova; Jiri Mayer
Journal:  Int J Infect Dis       Date:  2011-10-30       Impact factor: 3.623

8.  Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.

Authors:  Sophia Koo; Julie M Bryar; John H Page; Lindsey R Baden; Francisco M Marty
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

9.  Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis.

Authors:  C Cordonnier; F Botterel; R Ben Amor; C Pautas; S Maury; M Kuentz; Y Hicheri; S Bastuji-Garin; S Bretagne
Journal:  Clin Microbiol Infect       Date:  2008-12-20       Impact factor: 8.067

10.  Causes of death in a contemporary cohort of patients with invasive aspergillosis.

Authors:  Carolina Garcia-Vidal; Maddalena Peghin; Carlos Cervera; Carlota Gudiol; Isabel Ruiz-Camps; Asunción Moreno; Cristina Royo-Cebrecos; Eva Roselló; Jordi Puig de la Bellacasa; Josefina Ayats; Jordi Carratalà
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

View more
  10 in total

1.  Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus-specific Lateral Flow Device test in bronchoalveolar lavage.

Authors:  Jeffrey D Jenks; Sanjay R Mehta; Randy Taplitz; Saima Aslam; Sharon L Reed; Martin Hoenigl
Journal:  Mycoses       Date:  2019-01-15       Impact factor: 4.377

Review 2.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

3.  (New) Methods for Detection of Aspergillus fumigatus Resistance in Clinical Samples.

Authors:  Jeffrey D Jenks; Birgit Spiess; Dieter Buchheidt; Martin Hoenigl
Journal:  Curr Fungal Infect Rep       Date:  2019-06-20

Review 4.  Blood Aspergillus PCR: The Good, the Bad, and the Ugly.

Authors:  Matthias Egger; Jeffrey D Jenks; Martin Hoenigl; Juergen Prattes
Journal:  J Fungi (Basel)       Date:  2020-01-27

5.  Differential genes expression analysis of invasive aspergillosis: a bioinformatics study based on mRNA/microRNA.

Authors:  Maryam Hosseinipour; Shirin Shahbazi; Shahla Roudbar-Mohammadi; Maryam Khorasani; Majid Marjani
Journal:  Mol Biol Res Commun       Date:  2020-12

6.  zzm321990 Aspergillus fumigatus and Its Allergenic Ribotoxin Asp f I: Old Enemies but New Opportunities for Urine-Based Detection of Invasive Pulmonary Aspergillosis Using Lateral-Flow Technology.

Authors:  Genna Davies; Oski Singh; Juergen Prattes; Martin Hoenigl; Paul W Sheppard; Christopher R Thornton
Journal:  J Fungi (Basel)       Date:  2020-12-31

Review 7.  The Evolving Landscape of Fungal Diagnostics, Current and Emerging Microbiological Approaches.

Authors:  Zoe Freeman Weiss; Armando Leon; Sophia Koo
Journal:  J Fungi (Basel)       Date:  2021-02-09

Review 8.  Immune Parameters for Diagnosis and Treatment Monitoring in Invasive Mold Infection.

Authors:  Jeffrey D Jenks; Stephen A Rawlings; Carol Garcia-Vidal; Philipp Koehler; Toine Mercier; Juergen Prattes; Cornelia Lass-Flörl; M Teresa Martin-Gomez; Dieter Buchheidt; Livio Pagano; Jean-Pierre Gangneux; Frank L van de Veerdonk; Mihai G Netea; Agostinho Carvalho; Martin Hoenigl
Journal:  J Fungi (Basel)       Date:  2019-12-16

9.  Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement.

Authors:  Jeffrey D Jenks; Jean-Pierre Gangneux; Ilan S Schwartz; Ana Alastruey-Izquierdo; Katrien Lagrou; George R Thompson Iii; Cornelia Lass-Flörl; Martin Hoenigl
Journal:  J Fungi (Basel)       Date:  2020-10-11

Review 10.  Biosynthesis Pathways, Transport Mechanisms and Biotechnological Applications of Fungal Siderophores.

Authors:  Lorenzo Pecoraro; Xiao Wang; Dawood Shah; Xiaoxuan Song; Vishal Kumar; Abdul Shakoor; Keshawanand Tripathi; Pramod W Ramteke; Rupa Rani
Journal:  J Fungi (Basel)       Date:  2021-12-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.